Riboflavin

(Redirected from Vitamin B2)
Jump to: navigation, search

WikiDoc Resources for Riboflavin

Articles

Most recent articles on Riboflavin

Most cited articles on Riboflavin

Review articles on Riboflavin

Articles on Riboflavin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Riboflavin

Images of Riboflavin

Photos of Riboflavin

Podcasts & MP3s on Riboflavin

Videos on Riboflavin

Evidence Based Medicine

Cochrane Collaboration on Riboflavin

Bandolier on Riboflavin

TRIP on Riboflavin

Clinical Trials

Ongoing Trials on Riboflavin at Clinical Trials.gov

Trial results on Riboflavin

Clinical Trials on Riboflavin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Riboflavin

NICE Guidance on Riboflavin

NHS PRODIGY Guidance

FDA on Riboflavin

CDC on Riboflavin

Books

Books on Riboflavin

News

Riboflavin in the news

Be alerted to news on Riboflavin

News trends on Riboflavin

Commentary

Blogs on Riboflavin

Definitions

Definitions of Riboflavin

Patient Resources / Community

Patient resources on Riboflavin

Discussion groups on Riboflavin

Patient Handouts on Riboflavin

Directions to Hospitals Treating Riboflavin

Risk calculators and risk factors for Riboflavin

Healthcare Provider Resources

Symptoms of Riboflavin

Causes & Risk Factors for Riboflavin

Diagnostic studies for Riboflavin

Treatment of Riboflavin

Continuing Medical Education (CME)

CME Programs on Riboflavin

International

Riboflavin en Espanol

Riboflavin en Francais

Business

Riboflavin in the Marketplace

Patents on Riboflavin

Experimental / Informatics

List of terms related to Riboflavin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Riboflavin
File:Riboflavin.svg
Identifiers
CAS number 83-88-5
PubChem 1072
MeSH Riboflavin
Properties
Molecular formula C17H20N4O6
Molar mass 376.364
Melting point

290 °C (dec.)

Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Riboflavin (E101), also known as vitamin B2, is an easily absorbed micronutrient with a key role in maintaining health in animals. It is the central component of the cofactors FAD and FMN, and is therefore required by all flavoproteins. As such, vitamin B2 is required for a wide variety of cellular processes. Like the other B vitamins, it plays a key role in energy metabolism, and is required for the metabolism of fats, carbohydrates, and proteins.

Milk, cheese, leafy green vegetables, liver, legumes such as mature soybeans [1], yeast and almonds are good sources of vitamin B2, but exposure to light destroys riboflavin.

Toxicity

Riboflavin is not toxic when taken orally, as its low solubility keeps it from being absorbed in dangerous amounts from the gut [2]. Although toxic doses can be administered by injection[2], any excess at nutritionally relevant doses is excreted in the urine[3], imparting a bright yellow color when in large quantities.

Industrial synthesis

Various biotechnological processes have been developed for industrial scale riboflavin biosynthesis using different microorganisms, including filamentous fungi such as Ashbya gossypii, Candida famata and Candida flaveri as well as the bacteria Corynebacterium ammoniagenes and Bacillus subtilis[4]. The latter organism has been genetically modified to both increase the bacteria's production of riboflavin and to introduce an antibiotic (ampicillin) resistance marker, and is now successfully employed at a commercial scale to produce riboflavin for feed and food fortification purposes. The chemical company BASF has installed a plant in South Korea, which is specialized on riboflavin production using Ashbya gossypii. The concentrations of riboflavin in their modified strain are so high, that the mycelium has a reddish / brownish color and accumulates riboflavin crystals in the vacuoles, which will eventually burst the mycelium.

Riboflavin in food

Riboflavin is yellow or orange-yellow in color and in addition to being used as a food coloring it is also used to fortify some foods. It is used in baby foods, breakfast cereals, pastas, sauces, processed cheese, fruit drinks, vitamin-enriched milk products, some energy drinks, and is widely used in vitamin supplements.

Large quantities of riboflavin are often included in multi-vitamins; often, the dose is far more than a normal human can use in a day. The excess is excreted in the urine, causing the urine to be colored bright yellow within a few hours of ingestion of the vitamin.

It is difficult to incorporate riboflavin into many liquid products because it has poor solubility in water. Hence the requirement for riboflavin-5'-phosphate (E101a), a more expensive but more soluble form of riboflavin.

Nutrition

Riboflavin deficiency

Further information: Ariboflavinosis

Riboflavin is continuously excreted in the urine of healthy individuals[1], making deficiency relatively common when dietary intake is insufficient. However, riboflavin deficiency is always accompanied by deficiency of other vitamins[1].

A deficiency of riboflavin can be primary - poor vitamin sources in one's daily diet - or secondary, which may be a result of conditions that affect absorption in the intestine, the body not being able to use the vitamin, or an increase in the excretion of the vitamin from the body.

In humans, signs and symptoms of riboflavin deficiency (ariboflavinosis) include cracked and red lips, inflammation of the lining of mouth and tongue, mouth ulcers, cracks at the corners of the mouth (angular cheilitis), and a sore throat. A deficiency may also cause dry and scaling skin, fluid in the mucous membranes, and iron-deficiency anemia. The eyes may also become bloodshot, itchy, watery and sensitive to bright light.

Riboflavin deficiency is classically associated with the oral-ocular-genital syndrome. Angular cheilitis, photophobia, and scrotal dermatitis are the classic remembered signs.

In animals, riboflavin deficiency results in lack of growth, failure to thrive, and eventual death. Experimental riboflavin deficiency in dogs results in growth failure, weakness, ataxia, and inability to stand. The animals collapse, become comatose, and die. During the deficiency state, dermatitis develops together with hair-loss. Other signs include corneal opacity, lenticular cataracts, hemorrhagic adrenals, fatty degeneration of the kidney and liver, and inflammation of the mucus membrane of the gastrointestinal tract. Post-mortem studies in rhesus monkeys fed a riboflavin-deficient diet revealed that about one-third the normal amount of riboflavin was present in the liver, which is the main storage organ for riboflavin in mammals. These overt clinical signs of riboflavin deficiency are rarely seen among inhabitants of the developed countries. However, about 28 million Americans exhibit a common ‘sub-clinical’ stage, characterized by a change in biochemical indices (e.g. reduced plasma erythrocyte glutathione reductase levels). Although the effects of long-term sub-clinical riboflavin deficiency are unknown, in children this deficiency results in reduced growth. Subclinical riboflavin deficiency has also been observed in women taking oral contraceptives, in the elderly, in people with eating disorders, and in disease states such as HIV, inflammatory bowel disease, diabetes and chronic heart disease. The fact that riboflavin deficiency does not immediately lead to gross clinical manifestations indicates that the systemic levels of this essential vitamin are tightly regulated.

Diagnostic Testing of B2 Deficiency

A positive diagnostic test for measuring levels of riboflavin in serum is ascertained by measuring erythrocyte levels of glutathione reductase.

Clinical Uses

Riboflavin has been used in several clinical and therapeutic situations. For over 30 years, riboflavin supplements have been used as part of the phototherapy treatment of neonatal jaundice. The light used to irradiate the infants breaks down not only the toxin causing the jaundice, but the naturally occurring riboflavin within the infant's blood as well.

More recently there has been growing evidence that supplemental riboflavin may be a useful additive along with beta-blockers in the treatment of migraine headaches.

Development is underway to use riboflavin to improve the safety of transfused blood by reducing pathogens found in collected blood. Riboflavin attaches itself to the nucleic acids (DNA and RNA) in cells, and when light is applied, the nucleic acids are broken, effectively killing those cells. The technology has been shown to be effective for inactivating pathogens in all three major blood components: (platelets, red blood cells, and plasma). It has been shown to inactivate a broad spectrum of pathogens, including known and emerging viruses, bacteria, and parasites.

Recently riboflavin has been used in a new treatment to slow or stop the progression of the corneal disorder keratoconus. This is called corneal collagen crosslinking (C3R). In corneal crosslinking, riboflavin drops are applied to the patient’s corneal surface. Once the riboflavin has penetrated through the cornea, Ultraviolet A light therapy is applied. This induces collagen crosslinking, which increases the tensile strength of the cornea. The treatment has been shown in several studies to stabilise keratoconus.

Industrial Uses

Because riboflavin is fluorescent under UV light, dilute solutions (0.015-0.025% w/w) are often used to detect leaks or to demonstrate cleanability in an industrial system such a chemical blend tank or bioreactor. (See the ASME BPE section on Testing and Inspection for additional details.)

Good sources

Riboflavin is found naturally in asparagus, bananas, okra, chard, cottage cheese, milk, yogurt, meat, eggs, and fish, each of which contain at least 0.1 mg of the vitamin per 3-10.5 oz (85-300 g) serving.

See also

External links

  • Mirasol PRT includes a brief description of riboflavin as an agent to inactivate pathogens.

References

  1. 1.0 1.1 1.2 Brody, Tom (1999). Nutritional Biochemistry. San Diego: Academic Press. ISBN 0-12-134836-9. 
  2. 2.0 2.1 Unna, Klaus and Greslin, Joseph G. (1942). "Studies on the toxicity and pharmacology of riboflavin". J Pharmacol Exp Ther. 76 (1): 75–80. 
  3. Zempleni, J and Galloway, JR and McCormick, DB (1996). "Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans". Am J Clin Nutr. The American Society for Nutrition. 63 (1): 54–66. PMID 8604671. 
  4. Stahmann KP, Revuelta JL and Seulberger H. (2000). "Three biotechnical processes using Ashbya gossypii, Candida famata, or Bacillus subtilis compete with chemical riboflavin production". Appl Microbiol Biotechnol. 53 (5): 509–516. 
ar:فيتامين بي2

bs:Vitamin B2 ca:Riboflavina cs:Riboflavin de:Riboflavineo:Riboflavino fo:Riboflavingl:Vitamina B2 ko:바이타민 B2 hr:Vitamin B2 it:Riboflavina he:ויטמין B2 lb:Riboflavin lt:Riboflavinas hu:Riboflavin mk:Рибофлавин ms:Vitamin B2 nl:Riboflavineno:Riboflavinsq:Vitamina B2 simple:Riboflavin sk:Riboflavín sr:Витамин Б2 sh:Vitamin B2 su:Riboflavin fi:Riboflaviini sv:Riboflavinuk:Рибофлавін


Linked-in.jpg